FibroBiologics, Inc. Common Stock
General ticker "FBLG" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $10.7M (TTM average)
FibroBiologics, Inc. Common Stock does not follow the US Stock Market performance with the rate: -34.9%.
Estimated limits based on current volatility of 6.5%: low 1.18$, high 1.34$
Factors to consider:
- Total employees count: 15 (+15.4%) as of 2025
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Going concern doubt, Operational and conduct risks, Need additional capital, FDA approval delays, Stock price volatile
- Current price 62.6% below estimated low
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [3.31$, 11.36$]
- 2026-12-31 to 2027-12-31 estimated range: [3.04$, 9.94$]
Financial Metrics affecting the FBLG estimates:
- Negative: with PPE of -0.6 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: negative Operating cash flow
- Negative: negative Net income
- Positive: 58.56 < Shareholder equity ratio, % of 64.00 <= 69.38
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Positive: -2.60 < Investing cash flow per share per price, % of -2.40
- Negative: Industry earnings per price (median), % of -15.99 <= 0
Short-term FBLG quotes
Long-term FBLG plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $8.89MM | $13.74MM | $16.65MM |
| Operating Income | $-8.89MM | $-13.74MM | $-16.65MM |
| Non-Operating Income | $-7.60MM | $2.58MM | $-2.00MM |
| Interest Expense | $0.15MM | $0.02MM | $0.20MM |
| R&D Expense | $2.37MM | $4.50MM | $7.41MM |
| Income(Loss) | $-16.48MM | $-11.16MM | $-18.65MM |
| Net Income(Loss)* | $-16.48MM | $-11.16MM | $-18.65MM |
| Stockholders Equity | $1.25MM | $2.73MM | $6.16MM |
| Assets | $11.82MM | $16.45MM | $9.62MM |
| Operating Cash Flow | $-6.40MM | $-11.90MM | $-16.39MM |
| Capital expenditure | $0.49MM | $0.18MM | $0.26MM |
| Investing Cash Flow | $-0.49MM | $-0.18MM | $-0.26MM |
| Financing Cash Flow | $13.79MM | $16.91MM | $7.57MM |
| Earnings Per Share** | $-10.15 | $-6.79 | $-8.35 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.